These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3619193)

  • 1. Determination of minimal inhibitory concentrations of antituberculosis drugs by radiometric and conventional methods.
    Lee CN; Heifets LB
    Am Rev Respir Dis; 1987 Aug; 136(2):349-52. PubMed ID: 3619193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of MICs of conventional and experimental drugs in liquid medium by the radiometric method against Mycobacterium avium complex.
    Heifets LB; Iseman MD; Lindholm-Levy PJ
    Drugs Exp Clin Res; 1987; 13(9):529-38. PubMed ID: 3428133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimal inhibitory concentrations of isoniazid, rifampin, ethambutol, and streptomycin against Mycobacterium tuberculosis strains isolated before treatment of patients in Taiwan.
    Suo J; Chang CE; Lin TP; Heifets LB
    Am Rev Respir Dis; 1988 Oct; 138(4):999-1001. PubMed ID: 3144210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental "in vivo" studies of new antituberculosis drugs: capreomycin, ethambutol, rifampicin.
    Grumbach F
    Tubercle; 1969 Mar; 50():Suppl:12-21. PubMed ID: 5402543
    [No Abstract]   [Full Text] [Related]  

  • 5. Radiometric vs. agar proportion methods for assessing ethionamide resistance and its clinical effects in multidrug-resistant tuberculosis.
    Cimen NO; Arslan Z; Saygi A; Ocak K; Babacan F; Kurutepe M
    Int J Tuberc Lung Dis; 2009 Jul; 13(7):907-13. PubMed ID: 19555543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental studies on therapeutic effects of various combinations of antituberculosis drugs. II. Comparison of various regimens in treatment of experimental mouse tuberculosis infected with SM- and INH-resistant Schacht strain.
    Hokama S
    Jpn J Tuberc; 1967 Jul; 14(1):45-54. PubMed ID: 4295381
    [No Abstract]   [Full Text] [Related]  

  • 7. MIC as a quantitative measurement of the susceptibility of Mycobacterium avium strains to seven antituberculosis drugs.
    Heifets L
    Antimicrob Agents Chemother; 1988 Aug; 32(8):1131-6. PubMed ID: 2461162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advances and principles in tuberculostatic therapy].
    Bethge H
    Internist (Berl); 1971 Aug; 12(8):328-31. PubMed ID: 4328130
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 2. Results of rifampicin treatment for advanced pulmonary tuberculosis patients resistant to conventional antituberculous drugs].
    Kekkaku; 1971 Nov; 46(11):423-8. PubMed ID: 4335256
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drug therapy of tuberculosis].
    Jentgens H
    Dtsch Med Wochenschr; 1974 Aug; 99(32):1627-30. PubMed ID: 4135677
    [No Abstract]   [Full Text] [Related]  

  • 11. [Urgent problems of antibacterial treatment of pulmonary tuberculosis].
    Pilipchuk NS
    Vrach Delo; 1981 Jan; (1):47-9. PubMed ID: 7010782
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative studies of various antituberculosis drug regimens by means of serum antimycobacterial activity tests in man.
    Hokama S
    Jpn J Tuberc; 1967 Jul; 14(1):55-65. PubMed ID: 5300098
    [No Abstract]   [Full Text] [Related]  

  • 13. Radiometric and conventional drug susceptibility testing of Mycobacterium tuberculosis.
    Hoel T; Eng J
    APMIS; 1991 Nov; 99(11):977-80. PubMed ID: 1958354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to front line antituberculosis drugs and comparison with the radiometric BACTEC 460 TB method].
    Sinirtaş M; Ozakin C; Gedikoğlu S
    Mikrobiyol Bul; 2009 Jul; 43(3):403-9. PubMed ID: 19795615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days.
    Jindani A; Doré CJ; Mitchison DA
    Am J Respir Crit Care Med; 2003 May; 167(10):1348-54. PubMed ID: 12519740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rifampicin, isoniazid, ethambutol, ethionamide, and streptomycin in murine tuberculosis: comparative chemotherapeutic studies.
    Kradolfer F
    Antibiot Chemother; 1970; 16():352-60. PubMed ID: 5523730
    [No Abstract]   [Full Text] [Related]  

  • 17. Experimental studies on therapeutic effects of various combinations of antituberculosis drugs. I. Comparison of various regimens in treatment of experimental mouse tuberculosis infected with drug-susceptible mycobacteria.
    Hokama S
    Jpn J Tuberc; 1967 Jul; 14(1):29-44. PubMed ID: 5300097
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment modalities applied to tuberculosis patients in a French department. Hautes-Pyrénées, 1973 to 1980].
    Hetrick G; Humarau H
    Rev Fr Mal Respir; 1983; 11(6):883-7. PubMed ID: 6669799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rifabutine: minimal inhibitory and bactericidal concentrations for Mycobacterium tuberculosis.
    Heifets LB; Lindholm-Levy PJ; Iseman MD
    Am Rev Respir Dis; 1988 Mar; 137(3):719-21. PubMed ID: 2830815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter laboratory evaluation of the MB/BacT Mycobacterium detection system and the BACTEC MGIT 960 system in comparison with the BACTEC 460TB system for susceptibility testing of Mycobacterium tuberculosis.
    Garrigó M; Aragón LM; Alcaide F; Borrell S; Cardeñosa E; Galán JJ; Gonzalez-Martín J; Martin-Casabona N; Moreno C; Salvado M; Coll P
    J Clin Microbiol; 2007 Jun; 45(6):1766-70. PubMed ID: 17442793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.